Get my own profile
Public access
View all23 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Ylstra BaukeVU University Medical CenterVerified email at vumc.nl
- Gerrit A Meijerprofessor of oncologic pathology, Netherlands Cancer Institute, University Medical Center UtrechtVerified email at nki.nl
- van de Wiel MAVerified email at vumc.nl
- Hendrik van EssenAmsterdam UMCVerified email at amsterdamumc.nl
- Erik SistermansHead of Genome Diagnostics, Amsterdam University Medical CentersVerified email at amsterdamumc.nl
- Lodewyk WesselsProfessor of Computational Cancer BiologyVerified email at nki.nl
- Ton N.M. SchumacherThe Netherlands Cancer Institute, Third Rock VenturesVerified email at nki.nl
- Jos JonkersSenior Group Leader, Division of Molecular Pathology, Netherlands Cancer Institute, Oncode InstituteVerified email at nki.nl
- Daniel PinkelVerified email at ucsf.edu
- Carmen GerlachKarolinska InstitutetVerified email at ki.se
- Jeroen WJ van HeijstAcademic Medical Center, University of AmsterdamVerified email at amc.nl
- Koen SchepersLeiden University Medical CenterVerified email at lumc.nl
- EF. SmitHoogleraar longziektenVerified email at nki.nl
- Ilari ScheininVerified email at helsinki.fi
- Marcel ReindersProfessor of Computer Science, Delft University of TechnologyVerified email at tudelft.nl
- Renee MenezesBiostatistics Centre, Department of Psychosocial and Epidemiological Research, Netherlands CancerVerified email at nki.nl
- Michiel PegtelVerified email at vumc.nl
- Jaap Middeldorpprofessor @Amsterdam University medical center, PI @Cancer Center Amsterdam and CEO @ Cyto-Barr BVVerified email at amsterdamumc.nl
- Ramon ArensLeiden UniversityVerified email at lumc.nl
- Remond J.A. FijnemanNetherlands Cancer Institute, Amsterdam, The NetherlandsVerified email at nki.nl